课题基金 / 基金详情

Administrative Core

Administrative Core
行政核心
批准号:
10249383
负责人:
Karen Hsieh Lu
金额:
$0.4万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2022-08-31

项目摘要

项目成果

Karen Hsieh Lu的其他基金

相似基金

相关文献

中文摘要
翻译
行政核心摘要/摘要 MD安德森癌症中心子宫内膜癌孢子的总体目标是进行高度的 用于预防和治疗子宫内膜癌的创新性转化研究。为了确保 成功的孢子,行政核心将提供科学的监督,以及有效的 管理和管理与每个项目、核心和开发相关的所有活动 孢子研究/职业提升计划。行政核心将积极致力于 在我们的内部孢子调查人员内部交流和传播信息,以及促进 与其他孢子和外部赞助者的信息共享和合作。核心将提供一个 结构,将不同的科学学科整合为统一的多学科方法,以实现 在转化性子宫内膜癌研究方面表现出色。重要的是,行政核心将监测 制定时间表,并确保所有孢子项目的基础科学和临床试验目标都得到满足。这个 核心的目标是1)监督所有孢子活动,包括项目和核心;2)提供 为DRP和CEP提供行政支助;3)召集孢子执行委员会的所有会议(所有 计划联合领导和核心联合主任)、内部/外部咨询委员会和倡导者咨询 委员会;4)安排所有科学会议;5)协调数据质量控制和质量保证问题 与生物统计和生物信息学核心、病理学核心和生物标记核心合作;6) 监督和监督所有财政和预算问题;7)与其他监督委员会密切联系 与我们机构的子宫内膜癌研究有关,包括妇科肿瘤库 监督委员会;8)保持调查人员之间的沟通和协调研究,以及 与其他翻译研究人员、妇科癌症孢子、妇科肿瘤学小组和 通过分发材料、电子通信和进度报告,从其他疫点传播孢子; 8)与NCI项目官员和其他工作人员沟通,准备所有必要的报告和出版物;9) 及时将影响孢子管理的重要事态发展通知NCI项目官员 积极或消极;11)确保遵守所有一般、政府和NCI法规,并 12)制定和执行招募妇女和少数群体的政策。尊敬的卢凯伦博士, 行政核心的联合主任和整个孢子的联合首席调查员将指导这些 在行政核心联合主任和联合首席调查员协助下开展的活动 全体孢子,罗素·布罗德斯博士以及孢子管理人Heetae Kim先生。
英文摘要
Administrative Core SUMMARY/ ABSTRACT The overall goal of the Endometrial Cancer SPORE at MD Anderson Cancer Center is to conduct highly innovative translational research for the prevention and treatment of endometrial cancer. To ensure the success of the SPORE, the Administrative Core will provide scientific oversight, as well as effective management and administration of all activities relating to each Project, Core, and Developmental Research/Career Enhancement Program in the SPORE. The Administrative Core will actively work to communicate and disseminate information within our internal SPORE investigators as well as facilitate information sharing and collaborations with other SPOREs and external constituencies. The Core will provide a structure to integrate diverse scientific disciplines into a unified multidisciplinary approach for achieving excellence in translational endometrial cancer research. Importantly, the Administrative Core will monitor timelines and ensure both basic science and clinical trial aims are met for all SPORE projects. The objectives of the Core are to 1) oversee all SPORE activities, including Projects and Cores; 2) provide administrative support for the DRP and CEP; 3) convene all meetings of the SPORE Executive Committee (all Program Co-leaders and Core Co-directors), Internal/External Advisory Committees, and Advocate Advisory Committee; 4) schedule all scientific meetings; 5) coordinate data quality control and quality assurance issues in collaboration with the Biostatistics and Bioinformatics Core, Pathology Core, and Biomarkers Core; 6) monitor and oversee all fiscal and budgetary issues; 7) interface closely with the other oversight committees related to endometrial cancer research at our institution, including the Gynecological Oncology Tumor Bank Oversight Committee; 8) maintain communication and coordinate research among investigators, as well as with other translational researchers, gynecologic cancer SPOREs, the Gynecologic Oncology Group, and SPOREs from other disease sites by distributing materials, electronic communications, and progress reports; 8) communicate with the NCI Project Officer and other staff to prepare all required reports and publications; 9) notify the NCI Project Officer promptly of important developments that affect the management of the SPORE either positively or negatively; 11) assure compliance with all general, governmental, and NCI regulations and requirements; and 12) establish and implement policies for recruitment of women and minorities. Dr. Karen Lu, Co-Director of the Administrative Core and Co-Principal Investigator for the overall SPORE, will direct these activities with the assistance of the Co-Director of the Administrative Core and Co-Principal Investigator for the overall SPORE, Dr. Russell Broaddus, as well as the SPORE Administrator, Mr. Heetae Kim.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
Metformin for the Chemoprevention of Endometrial Cancer In Obese, Insulin-Resista
Training of Academic Gynecologic Oncologists
Training of Academic Gynecologic Oncologists
海外基金